Designed Ankyrin Repeat Protein (darpin) to Target Chimeric Antigen Receptor (Car)-Redirected T Cells Towards CD4+ T Cells to Reduce the Latent HIV+ Cell Reservoir.
Medical Microbiology and Immmunology(2020)
Abstract
Chimeric Antigen Receptor (CAR)-redirected T cells show great efficacy in the patient-specific therapy of hematologic malignancies. Here, we demonstrate that a DARPin with specificity for CD4 specifically redirects and triggers the activation of CAR engineered T cells resulting in the depletion of CD4+ target cells aiming for elimination of the human immunodeficiency virus (HIV) reservoir.
MoreTranslated text
Key words
DARPin,CAR T cells,HIV reservoir,T cell therapy
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined